Michael J. Wick
Michael J. Wick publishes mostly in Oncology, Molecular Biology and Pulmonary and Respiratory Medicine, on topics such as HER2/EGFR in Cancer Research, Cancer Genomics and Diagnostics and Cancer Research and Treatments.
- World rank
- #311,765 of 7,710,434 ranked researchers
- Rank in United States
- #112,841 of 1,627,098
- Works
- 298
- Citations
- 3.8k
- Citations per work
- 12.6
What does Michael J. Wick research?
Michael J. Wick's work is mostly in Medicine (33%), Biochemistry, Genetics and Molecular Biology (29%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else11338.0%
- Health Sciences9832.8%
- Medicine9832.8%
- Life Sciences8729.2%
- 1Oncology17% of their works
- 2Molecular Biology16% of their works
- 3Pulmonary and Respiratory Medicine10% of their works
- 4Cancer Research9% of their works
- 5Radiology, Nuclear Medicine and Imaging6% of their works
- 6Biotechnology4% of their works
Research topics
Which keywords describe Michael J. Wick's research?
The keywords of their largest research topics: Breast Cancer, Targeted Therapy, HER2, Trastuzumab, Cancer Genomics, Mutational Signatures, Bacterial Therapy and Tumor Targeting.
- Therapeutic Antibodies
- Fc Receptors
- Adenoid Cystic Carcinoma
- mTOR
- Palbociclib
- Tumor Targeting
- Mutational Signatures
- Trastuzumab
- Targeted Therapy
- Breast Cancer
- HER2
- Cancer Genomics
- Bacterial Therapy
- CDK4/6 Inhibitors
- Signaling
- ALK Inhibitors
- EGFR Mutations
- Salivary Gland Tumors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Breast Cancer502 topics
- Targeted Therapy392 topics
- HER2301 topic
- Trastuzumab301 topic
- Cancer Genomics261 topic
- Mutational Signatures261 topic
- Bacterial Therapy241 topic
- Tumor Targeting241 topic
- CDK4/6 Inhibitors201 topic
- Palbociclib201 topic
- Signaling161 topic
- mTOR161 topic
- ALK Inhibitors131 topic
- Adenoid Cystic Carcinoma131 topic
- EGFR Mutations131 topic
- Fc Receptors131 topic
- Salivary Gland Tumors131 topic
- Therapeutic Antibodies131 topic
Where does Michael J. Wick work?
Michael J. Wick's main affiliation in the publication record is South Texas Accelerated Research Therapeutics, United States.
How many publications and citations does Michael J. Wick have?
OpenAlex counts 298 works and 3,764 citations for Michael J. Wick, an h-index of 30, ranking #311,765 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Michael J. Wick. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.